troglitazone has been researched along with atrasentan in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kantoff, PW; Kennedy, A; Majeed, N; Padley, RJ; Pollak, M; Tolcher, AW | 1 |
1 other study(ies) available for troglitazone and atrasentan
| Article | Year |
|---|---|
Other novel agents: Rationale and current status as chemopreventive agents.
Topics: Anticarcinogenic Agents; Atrasentan; Chromans; Humans; Male; Prostatic Neoplasms; Pyrrolidines; Receptors, Endothelin; Somatomedins; Thiazoles; Thiazolidinediones; Troglitazone; Trypsin Inhibitor, Bowman-Birk Soybean; Trypsin Inhibitors | 2001 |